Moonshots and metastatic disease: the need for a multi-faceted approach when studying atypical responses
Abstract Clinical research generally focuses on results involving a statistical mean with little attention in trial design to patients who respond considerably better or worse than average. Exploring the reasons underlying an “atypical response” will increase understanding of the mechanisms involved...
Main Authors: | Kristine De La Torre, Elly Cohen, Anne Loeser, Marc Hurlbert, on behalf of the Metastatic Breast Cancer Alliance |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2017-03-01
|
Series: | npj Breast Cancer |
Online Access: | https://doi.org/10.1038/s41523-017-0010-1 |
Similar Items
-
Moonshot Science—Risks and Benefits
by: Arturo Casadevall, et al.
Published: (2016-08-01) -
Moonshots and the New Industrial Policy Questioning the Mission Economy
Published: (2024) -
Moonshot innovations: Wishful Thinking or Business-As-Usual?
by: Anne-Laure Mention, et al.
Published: (2019-05-01) -
The study of applying co-occurrence of classification symbols in detecting the technology evolvement in US Cancer Moonshot related patents
by: Wei-Ming Tu, et al.
Published: (2018) -
Biobank integration of large-scale clinical and histopathology melanoma studies within the European Cancer Moonshot Lund Center
by: Johan Malm, et al.
Published: (2018-08-01)